Actelion (now Janssen Pulmonary Hypertension)
Executive AI transformation, platform consolidation, governance, eval, and scaled deployment.
Actelion (now Janssen Pulmonary Hypertension) is operationalizing agent readiness, with enough visible foundation to move beyond experimentation. Its strongest signals are a credible data and retrieval base, a mature AI and data tool mix, and hands-on agent and AI build capacity. The stack looks balanced across AI and data layers. Signals include Anthropic Claude and Databricks, but readiness is broader than any named tool. The main gaps are that production governance and measurement need clearer proof and AI hiring momentum appears selective. Next step: make governance, measurement, and repeatable delivery as clear as the build capacity.
Six pillars
Archetype: Agent App Builders
Companies showing agent frameworks, agent builders, MCP, coding assistants, or AI workflow construction signals.
Cluster: AI Scale Leaders
Production-shaped AI stack with visible investment momentum.
Engagement motionExecutive AI transformation, platform consolidation, governance, eval, and scaled deployment.
Strengths
- Data Foundation + Retrieval / Vector — Strong
- AI-Native / Agentic Build Capacity — Strong
- Stack Balance + Tool Mix Quality — Strong
Lowlights
- Eval, Observability, Governance — limited visible signal
- None
Similar companies
Applied Materials appears to be operationalizing agent readiness within the Agent App Builders archetype.
Fred Haas Toyota World appears to be operationalizing agent readiness within the Agentic Scale Leaders archetype.
Lockheed Martin appears to be operationalizing agent readiness within the Agentic Scale Leaders archetype.
Emerson appears to be operationalizing agent readiness within the Agent App Builders archetype.
Workato appears to be operationalizing agent readiness within the Governed AI Operators archetype.
Boehringer Ingelheim appears to be operationalizing agent readiness within the Agentic Scale Leaders archetype.